Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Antiviral Res. 2008 Feb 4;78(3):223–229. doi: 10.1016/j.antiviral.2008.01.005

Fig. 1.

Fig. 1

Aerosol characteristics of MegaRibavirin (100 mg/mL) generated from an Aerotech II nebulizer flowing at 10 L of air/min. A. Ribavirin distribution by particle size as determined by collection on an Andersen cascade impactor, elution of drug from the plates for each particle size range and quantitation by spectrophotometer (absorption at 207 nm). B. Ribavirin concentrations in the aerosol and nebulizer reservoir during a 30-min nebulization with an Aerotech II nebulizer. MMAD, mass median aerodynamic diameter; GSD, geometric standard deviation; AerosolMT, mean aerosol concentration of ribavirin over the 30 min period (μg/L of aerosol).